Follow along as Valkyrie's Head of Portfolio Management, Bill Cannon, highlights a notable "byte" from the markets each week.
Exciting blockchain utility in medicine is being developed as the technology is helping support clinical trial design, data management, and research. A partnership was announced this week between the world renown Mayo Clinic and Triall, a Dutch blockchain company using decentralized technologies for eClinical solutions.
The purpose of the collaboration is to demonstrate an immutable public ledger audit trail through its blockchain technology to boost the integrity of clinical trials. Investigators, regulators and stakeholders can then review and assess such trial-related data with trust, knowing that no one can modify the records.
Societal advancements using blockchain are growing, demonstrating the need for secure, transparent, and economical platforms accessible to all. Please find more details on the articles posted here.